Erratum to: Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus

SCHEEN, André

doi:10.1007/s40262-014-0205-7

Other (Scientific journals)

Erratum to: Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus

SCHEEN, André

2014 • In Clinical Pharmacokinetics, 53 (11), p. 1061

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/183190

DOI
10.1007/s40262-014-0205-7

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

2015 clin pharm erratum liver.pdf

Author postprint (41.31 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Pharmacy, pharmacology & toxicology
Endocrinology, metabolism & nutrition

Author, co-author :

SCHEEN, André ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

Language :

English

Title :

Erratum to: Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus

Publication date :

2014

Journal title :

Clinical Pharmacokinetics

ISSN :

0312-5963

eISSN :

1179-1926

Publisher :

Adis International, Auckland, New Zealand

Volume :

Issue :

Pages :

1061

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 24 June 2015

Statistics

Number of views

39 (0 by ULiège)

Number of downloads

121 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations